There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Researchers analysed data from 150 adults with T1D, divided into semaglutide, tirzepatide, and control groups.